What is already known about this subject Fluoroquinolone antibiotics have been associated with multi-system adverse effects involving the musculoskeletal, neuropsychiatric and sensory systems, prompting FDA and EMA regulatory restrictions. Conventional pharmacovigilance methods evaluate adverse events individually and are not designed to detect patterns of co-occurrence spanning multiple organ systems within the same report.
S. M. Abdullah
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with S. M.
Contact S. M., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack